BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6631043)

  • 1. [Breast cancer induced by estrogens in a prostate cancer patient].
    Suhler A; Naman H; Masselot R; Varini JP; Claudel P
    J Urol (Paris); 1983; 89(5):355-9. PubMed ID: 6631043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of the breast in patients having prostatic cancer treated with estrogens. Report of three cases (author's transl)].
    Dore B; Dombriz M; Denis P; Darracq-Paries JC; Barbier J; Aubert J
    J Urol (Paris); 1982; 88(4):247-52. PubMed ID: 7108255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma.
    Schlappack OK; Braun O; Maier U
    Cancer Detect Prev; 1986; 9(3-4):319-22. PubMed ID: 3017556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].
    Bülow H; Wullstein HK; Böttger G; Schröder FH
    Urologe A; 1973 Sep; 12(5):249-53. PubMed ID: 4357698
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytology and immunocytochemistry of bilateral breast metastases from prostatic cancer. Report of a case.
    Schmitt FC; Tani E; Skoog L
    Acta Cytol; 1989; 33(6):899-902. PubMed ID: 2480045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An infrequent form of metastasis of carcinoma of the prostate].
    Zabala Egurrola JA; Pertusa Peña C; Llarena Ibarguren R; Arruza Echevarría A; Arregui Erbina P; del Tanago JG
    Arch Esp Urol; 1989 Oct; 42(8):796-8. PubMed ID: 2619348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastases of prostate cancer express estrogen receptor-beta.
    Lai JS; Brown LG; True LD; Hawley SJ; Etzioni RB; Higano CS; Ho SM; Vessella RL; Corey E
    Urology; 2004 Oct; 64(4):814-20. PubMed ID: 15491740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated carcinoma of the prostate: monotherapy or complete androgenic blockade?].
    González Martín M; Gómez Veiga F; Alvarez Castelo L
    Arch Esp Urol; 1997 Dec; 50(10):1067-76. PubMed ID: 9494195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bilateral breast metastases from prostatic carcinoma: a case report].
    Soda T; Onishi H; Terachi T; Oishi K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1999 Apr; 45(4):269-71. PubMed ID: 10363149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of immunohistochemistry to the diagnosis of breast cancer in men.
    Aziz DC; Milne C; Solomon S; Jothy SP
    Can J Surg; 1986 Mar; 29(2):135-6. PubMed ID: 2420431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?
    Karlsson CT; Malmer B; Wiklund F; Grönberg H
    J Urol; 2006 Aug; 176(2):538-43. PubMed ID: 16813884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D; Barros H; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progesterone and breast cancer].
    Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
    Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of menopause and cancer of the breast: point of view of the hormonologist].
    Bricaire C
    Rev Prat; 1993 Dec; 43(20):2610-3. PubMed ID: 8146559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.